Hepatic fibrosis

Common Name(s)

Hepatic fibrosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatic fibrosis" returned 383 free, full-text research articles on human participants. First 3 results:

Upregulation of Epac-1 in Hepatic Stellate Cells by Prostaglandin E2 in Liver Fibrosis Is Associated with Reduced Fibrogenesis.
 

Author(s): Marlies Schippers, Leonie Beljaars, Eduard Post, Sophie Lotersztajn, Catharina Reker-Smit, Bing Han, Pablo Munoz-Llancao, Martina Schmidt, Klaas Poelstra

Journal: J. Pharmacol. Exp. Ther.. 2017 Nov;363(2):126-135.

 

Exchange protein activated by cAMP (Epac-1) is an important signaling mechanism for cAMP-mediated effects, yet factors that change Epac-1 levels are unknown. Such factors are relevant because it has been postulated that Epac-1 directly affects fibrogenesis. Prostaglandin E2 (PGE2) ...

Last Updated: 2 Sep 2017

Go To URL
Evaluation of Rumex hastatus leaves against hepatic fibrosis: a rat model.
 

Author(s): Sumaira Sahreen, Muhammad Rashid Khan, Rahmat Ali Khan

Journal:

 

Rumex hastatus leaves have been widely used as food additive and for the treatment of various liver ailments. According to our previous studies, ethyle acetate (ERL) and methanolic (MRL) fractions of R. hastatus leaves are an accessible source of natural antioxidants. In the present ...

Last Updated: 31 Aug 2017

Go To URL
EFFECT OF RUANGANJIEDU DECOCTION INHIBIT EXPERIMENTAL HEPATIC FIBROSIS OF RATS.
 

Author(s): Sheng Liu, Xiao-Min Wang, Guo-Wang Yang

Journal:

 

RuanGanJieDu (RGJD) is a traditional Chinese medicine comprising nine Chinese medicinal herbs. The clinical use of RGJD by us was found that it has a good control effect on hepatic fibrosis (HF) patient. In order to further investigate the Anti-fibrosis mechanism of RGJD, hence this ...

Last Updated: 8 May 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatic fibrosis" returned 62 free, full-text review articles on human participants. First 3 results:

Acoustic Radiation Force Impulse (ARFI) Elastography for non‑invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis.
 

Author(s): Xiangdong Hu, Lanyan Qiu, Dong Liu, Linxue Qian

Journal: Med Ultrason. 2017 Jan;19(1):23-31.

 

The purpose of the study was to assess the effect of Acoustic Radiation Force Impulse (ARFI) elastography in the diagnosis of liver fibrosis in chronic hepatitis B and C patients through Meta-analysis.

Last Updated: 9 Feb 2017

Go To URL
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
 

Author(s): Chong-Yang Zhang, Wei-Gang Yuan, Pei He, Jia-Hui Lei, Chun-Xu Wang

Journal: World J. Gastroenterol.. 2016 Dec;22(48):10512-10522.

 

Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity, and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to hepatocellular carcinoma in the absence of liver transplantation. Fibrosis generally results from ...

Last Updated: 13 Jan 2017

Go To URL
Hepatic steatosis and fibrosis: Non-invasive assessment.
 

Author(s): Rustam N Karanjia, Mary M E Crossey, I Jane Cox, Haddy K S Fye, Ramou Njie, Robert D Goldin, Simon D Taylor-Robinson

Journal: World J. Gastroenterol.. 2016 Dec;22(45):9880-9897.

 

Chronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and scarring, resulting in end-stage liver disease and its complications. The progression of disease is characterised by ongoing inflammation ...

Last Updated: 26 Dec 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

S-Shearwave Elastography for Assessment of Hepatic Fibrosis
 

Status: Not yet recruiting

Condition Summary: Liver Fibroses

 

Last Updated: 8 Feb 2017

Go to URL
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
 

Status: Recruiting

Condition Summary: Chronic Hepatitis B; Hepatic Fibrosis; Fatty Liver

 

Last Updated: 13 Oct 2016

Go to URL
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
 

Status: Recruiting

Condition Summary: Liver Fibrosis

 

Last Updated: 12 Jan 2016

Go to URL